Glycolipid A mimetics ? its chemo-enzymatic synthesis and immunological testing
Public support
Provider
Ministry of Education, Youth and Sports
Programme
COST
Call for proposals
COST 2 (SMSM200232004)
Main participants
Mikrobiologický ústav AV ČR, v. v. i.
Contest type
VS - Public tender
Contract ID
—
Alternative language
Project name in Czech
Deriváty glykolipidu A, jeho chemoenzymatická syntéza a imunologické testování
Annotation in Czech
Budou připraveny nové prekursory glykolipidu A pomocí chemoenzymatických metod na bázi chitooligomerů a aminosacharidů. Nové deriváty glykolipidu A připravené dalšími členy mezinárodního konsorcia (WG) budou testovány na imunogenicitu a toxicitu. Předpok, ládaným výsledkem by mělo být glykomimetikum, které by byly použitelné v terapii septického šoku., ,
Scientific branches
R&D category
—
CEP classification - main branch
CE - Biochemistry
CEP - secondary branch
EC - Immunology
CEP - another secondary branch
EI - Biotechnology and bionics
OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)
10608 - Biochemistry and molecular biology<br>10609 - Biochemical research methods<br>20801 - Environmental biotechnology<br>20802 - Bioremediation, diagnostic biotechnologies (DNA chips and biosensing devices) in environmental management<br>20803 - Environmental biotechnology related ethics<br>20901 - Industrial biotechnology<br>20902 - Bioprocessing technologies (industrial processes relying on biological agents to drive the process) biocatalysis, fermentation<br>20903 - Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials<br>30102 - Immunology<br>30401 - Health-related biotechnology<br>30402 - Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)<br>30403 - Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions [pharmacogenomics, gene-based therapeutics])<br>30404 - Biomaterials (as related to medical implants, devices, sensors)<br>30405 - Medical biotechnology related ethics<br>40401 - Agricultural biotechnology and food biotechnology<br>40402 - GM technology (crops and livestock), livestock cloning, marker assisted selection, diagnostics (DNA chips and biosensing devices for the early/accurate detection of diseases) biomass feedstock production technologies, biopharming<br>40403 - Agricultural biotechnology related ethics
Completed project evaluation
Provider evaluation
V - Vynikající výsledky projektu (s mezinárodním významem atd.)
Project results evaluation
4 publikace v impaktovaných časopisech, příprava nových látek, vypracování původní metodiky testování, biologické testování
Solution timeline
Realization period - beginning
Jan 1, 2002
Realization period - end
Jan 1, 2003
Project status
U - Finished project
Latest support payment
—
Data delivery to CEP
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data delivery code
CEP/2004/MSM/MSM4OC/U/N/2:1
Data delivery date
Jun 16, 2004
Finance
Total approved costs
1,131 thou. CZK
Public financial support
726 thou. CZK
Other public sources
0 thou. CZK
Non public and foreign sources
405 thou. CZK